Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go to Privacy Statement

  • b2banner01.jpg b2banner01ph.jpg

    Leadership

Executive Team

b2img01-771.png

Mark G LOTTER

  • 20+ years China healthcare industry experience

  • Serial entrepreneur

  • Established AstraZeneca China commercial operations

  • Pioneered AZ China nebulization strategy

Mark G LOTTER

Founder / CEO

b2img04-199.png

Bob SHEN

  • 19+ years strong track record with both companies and investors

  • 8-year with WuXi AppTec, successfully launching A+H IPOs

  • Senior finance leaders in top MNC including TE, Saint-Gobain, GE

  • Audit and assurance role in PwC

Bob SHEN

Chief Financial Officer

b2img06-976.png

Charlie CHEN

  • Commercial and BD leadership roles with AstraZeneca China across Therapeutic Areas

  • Associate Partner and co-leader of healthcare practice with McKinsey, experience in strategy, commercial, R&D with MNCs and local biotech

  • Pharmaceutical formulation PhD, Cambridge University

Charlie CHEN

Chief Operating Officer

b2img05.png

Haijin MENG

  • 25+ years R&D experience in UCLA, CAS, Pfizer, etc.

  • Head of Early Clinical Research in BMS China, VP and CMO for Gloria Biosciences and CSO for SPH-Biocad

  • Medical training in China, PhD and Post-Doc training in the U.S.

Haijin MENG

Chief Medical Officer

b2img01-771.png

Mark G LOTTER

  • 20+ years China healthcare industry experience

  • Serial entrepreneur

  • Established AstraZeneca China commercial operations

  • Pioneered AZ China nebulization strategy

Mark G LOTTER

Founder / CEO

b2img04-199.png

Bob SHEN

  • 19+ years strong track record with both companies and investors

  • 8-year with WuXi AppTec, successfully launching A+H IPOs

  • Senior finance leaders in top MNC including TE, Saint-Gobain, GE

  • Audit and assurance role in PwC

Bob SHEN

Chief Financial Officer

b2img06-976.png

Charlie CHEN

  • Commercial and BD leadership roles with AstraZeneca China across Therapeutic Areas

  • Associate Partner and co-leader of healthcare practice with McKinsey, experience in strategy, commercial, R&D with MNCs and local biotech

  • Pharmaceutical formulation PhD, Cambridge University

Charlie CHEN

Chief Operating Officer

b2img05.png

Haijin MENG

  • 25+ years R&D experience in UCLA, CAS, Pfizer, etc.

  • Head of Early Clinical Research in BMS China, VP and CMO for Gloria Biosciences and CSO for SPH-Biocad

  • Medical training in China, PhD and Post-Doc training in the U.S.

Haijin MENG

Chief Medical Officer

CONTACT

Suite 639, East Tower, No 1376 Nan Jing West Road, Shanghai. 200040

Copyright 2022 NUANCE BIOTECH INC reserved. 沪ICP备17029781号-4